4//SEC Filing
Gray Cameron 4
Accession 0000899243-20-026662
CIK 0001645460other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:13 PM ET
Size
6.6 KB
Accession
0000899243-20-026662
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Purchase
Common Stock
2020-09-29$15.00/sh+5,000$75,000→ 672,500 total - Purchase
Common Stock
2020-09-30$15.30/sh+5,000$76,500→ 677,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.20 to $15.30, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001590583
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:13 PM ET
- Size
- 6.6 KB